NR4A1 and hepatocellular carcinoma: Consistent with our results, Nr4a1 promotes gluconeogenesis and suppresses glycolysis by attenuating sumoylation-regulated Pck stability in an acetylation-dependent manner in human hepatoma cell lines [46].